Patent: 6,251,666
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,251,666
Title: | Nucleic acid catalysts comprising L-nucleotide analogs |
Abstract: | A nucleic acid catalyst comprising at least one L-nucleotide substitution. |
Inventor(s): | Beigelman; Leonid (Longmont, CO) |
Assignee: | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) |
Application Number: | 09/048,825 |
Patent Claims: | see list of patent claims |
Details for Patent 6,251,666
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2017-03-31 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2017-03-31 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2017-03-31 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |